reports
Laureate Education Inc: 1 director
A director at Laureate Education Inc sold/sold after exercising options 61,803 shares at 33.694USD and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's dire...
iRhythm Holdings Appoints Jason Patten to its Board of Directors
iRhythm Holdings Appoints Jason Patten to its Board of Directors SAN FRANCISCO, March 12, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, is pleased to announce the appointment of Jason Patten to its Board of Directors, effective March 12, 2026. Mr. Patten brings decades of strategic leadership in healthcare, reinforcing iRhythm’s commitment to innovation, operational excellence, and long-term growth. “We are thrilled to welcome Jason Patten to our Board ...
ATI INC: 1 director
A director at ATI INC sold 6,609 shares at 154.254USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing...
Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Marke...
Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum CHASKA, Minn., March 10, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will participate in the upcoming KeyBanc Capital Markets Healthcare Virtual Forum. Details regarding Lifecore’s participation are as follows: 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum Details: Mr. Josephs will be a featured speaker in a fireside chat...
ASP Isotopes to Participate in Canaccord Genuity’s 2nd Annual CG Virtu...
ASP Isotopes to Participate in Canaccord Genuity’s 2nd Annual CG Virtual Sustainability Summit DALLAS, March 10, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that Paul Mann, Chief Executive Officer, will participate in a fireside chat at Canaccord Genuity’s 2nd Annual CG Virtual Sustainability Summit on Thursday, March 12, 2026, at 3:20 p.m. ET. A live audio webcast of the prese...
Aeluma Names Christiane Poblenz Vice President of Materials Operations
Aeluma Names Christiane Poblenz Vice President of Materials Operations Key Appointment to Drive Scaling of Wafer Production for Growing Markets GOLETA, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum, announced today it has named Christiane Poblenz as its Vice President of Materials Operations to lead scaling efforts for Aeluma’s large-diameter epitaxial wafers. Christiane Poblenz brings 25 years of exper...
Lifecore Biomedical to Report Financial Results for the Fourth Quarter...
Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026 Webcast Scheduled for Monday, March 16 at 8:30 a.m. Eastern CHASKA, Minn., March 09, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that it will report financial results for the fourth quarter and transition period ended December 31, 2025, on Monday, March 16, 2026, before the market opens. At 8:30 a.m. Eastern Time t...
Westwood Announces Monthly Income Distributions for Westwood Salient E...
Westwood Announces Monthly Income Distributions for Westwood Salient Enhanced Midstream Income ETF (MDST), Westwood Salient Enhanced Energy Income ETF (WEEI) and Westwood Enhanced Income Opportunity (YLDW) DALLAS, March 09, 2026 (GLOBE NEWSWIRE) -- (WHG), a publicly-traded investment management boutique and wealth management firm, today announced monthly income distributions for , and Westwood Enhanced Income Opportunity (YLDW) as shown in the table below. Part of the , these deliver income from both dividends and options premiums to help provide monthly income distributions for invest...
Comstock Resources Inc: 1 director
A director at Comstock Resources Inc sold 48,915 shares at 21.205USD and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Ru...
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CAMBRIDGE, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to one new employee. Fulcrum granted stock options to purchase shares of the company’s common stock pursuant to the company’s 2022 Inducement Stock Incentive Plan, as amended, or the plan, as...
Quantum Leap Energy Enters into Memorandum of Understanding with a Lar...
Quantum Leap Energy Enters into Memorandum of Understanding with a Large U.S. Energy Company Regarding Evaluation of Support to Advance Domestic Enriched Uranium Fuel Supply Chain Marks an important step toward enhancing the domestic supply chain for nuclear fuel in the United States Advances QLE’s strategy to build U.S.-based capabilities to support advanced nuclear fuel production DALLAS, March 06, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced that Quantum Leap Energy LLC (“QLE” or the “Company”), a wholly-owned subsidiary of ASPI dedicated to adva...
- Wedbush Research
SHOP SHOPIFY INC.
MELI MERCADOLIBRE INC.
KURA KURA ONCOLOGY INC.
GOOGL ALPHABET INC. CLASS A
FB FACEBOOK INC. CLASS A
ETSY ETSY INC.
EBAY EBAY INC.
NFLX NETFLIX INC.
CCRN CROSS COUNTRY HEALTHCARE INC.
WVE WAVE LIFE SCIENCES
CVNA CARVANA CO. CLASS A
AMZN AMAZON.COM INC.
BKNG BOOKING HOLDINGS INC.
CHWY CHEWY INC. CLASS A
STTK SHATTUCK LABS
KROS KEROS THERAPEUTICS
DASH DOORDASH
ABNB AIRBNB INC. CLASS A
DAWN DAY ONE BIOPHARMACEUTICALS INC
XMTR XOMETRY
TNGX INC.
ELYM TANGO THERAPEUTICS
APP INC
TTD ELIEM THERAPEUTICS INC
CMPX APPLOVIN CORP
RGTI THE TRADE DESK
EWTX INC.
CART COMPASS THERAPEUTICS
TLX RIGETTI COMPUTING INC
BBOT EDGEWISE THERAPEUTICS INC
MAPLEBEAR INC.
TELIX PHARMACEUTICALS LIMITED
BRIDGEBIO ONCOLOGY THERAPEUTICS INC
- Antoine Legault
- Matthew Bryson
Quantum Leap Energy Appoints Nate Salpeter, Ph.D., a Key Opinion Leade...
Quantum Leap Energy Appoints Nate Salpeter, Ph.D., a Key Opinion Leader in Fluid Dynamics and Energy Technology, as its Chief Technology Officer Former TerraPower and Kairos Power engineer brings proven track record of scaling advanced energy technologies DALLAS, March 05, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced that Quantum Leap Energy LLC (“QLE” or the “Company”), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, has appointed N...
Titan Machinery Inc. to Report Fiscal Fourth Quarter and Full Year End...
Titan Machinery Inc. to Report Fiscal Fourth Quarter and Full Year Ended January 31, 2026 Results on Thursday, March 19, 2026 WEST FARGO, N.D., March 05, 2026 (GLOBE NEWSWIRE) -- Titan Machinery Inc. (Nasdaq: TITN), a leading network of full-service agricultural and construction equipment stores, announced today it will release financial results for the fourth quarter and full year ended January 31, 2026, on Thursday, March 19, 2026, followed by an investor conference call at 7:30 a.m. Central time (8:30 a.m. Eastern time). Investors interested in participating in the live call can dial ...
IES Holdings Inc: 1 director
A director at IES Holdings Inc sold 2,500 shares at 501.957USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
Rigetti Computing Reports Fourth Quarter and Full-Year 2025 Financial ...
Rigetti Computing Reports Fourth Quarter and Full-Year 2025 Financial Results Demonstrates 99.9% two-qubit gate fidelity at 28 nanosecond gate speed on prototype platform BERKELEY, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced its financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter and Full-Year 2025 Financial Highlights Total revenues for the three months ended December 31, 2025 were $1.9 millionOperating loss for...
Lifecore Biomedical Signs New Agreement with Indomo to Support Innovat...
Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment Indomo Developing Fast-Acting, At-Home Treatment for Inflammatory Acne Lesions to be Administered with the ClearPen™, its Proprietary Intradermal Self-Injection Device Lifecore to Manufacture Drug Batches in Preparation for Planned Clinical Trials CHASKA, Minn. and BOSTON, Mass., March 04, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), and Indomo, a clini...
Fulcrum Therapeutics to Participate in the Leerink Partners Global Hea...
Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference CAMBRIDGE, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that company management will present at the Leerink Partners Global Healthcare Conference in Miami, FL on Tuesday, March 10, 2025 at 1:00 p.m. ET. The webcast of the presentation will be accessible or by visiting the "Eve...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.